Spotlight
Video

Exploratory analysis of frontline therapies in REVEL: Phase 3 trial of ramucirumab in lung cancer | Prof Giorgio Scagliotti at ECC 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the European Cancer Congress (ECC) 2015, Giorgio V. Scagliotti, MD, PhD, of the University of Turin, Turin, Italy, discusses the exploratory analysis of frontline therapies in REVEL, a randomised phase 3 clinical trial of ramucirumab plus docetaxel versus docetaxel for the treatment of patients with stage 4 non-small cell lung cancer after disease progression on platinum-based therapy.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 10/09/15
Added : 2 years ago



Recommended

Nothing found.

More From EMJ

Nothing found.